Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
Over the last 12 months, insiders at Delcath Systems, Inc. have bought $1.08M and sold $0 worth of Delcath Systems, Inc. stock.
On average, over the past 5 years, insiders at Delcath Systems, Inc. have bought $775,922 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Vukovic Vojo (Chief Medical Officer) — $806,400. Rosalind Advisors, Inc. (director) — $240,410. MICHEL GERARD J (Chief Executive Officer) — $199,920.
The last purchase of 26,882 shares for transaction amount of $100,001 was made by SALAMON STEVEN A J (director) on 2024‑03‑19.
2024-03-19 | SALAMON STEVEN A J | director | 26,882 0.106% | $3.72 | $100,001 | +30.37% | ||
2024-03-19 | Aharon Gil | director | 26,882 0.106% | $3.72 | $100,001 | +30.37% | ||
2023-12-12 | Vukovic Vojo | Chief Medical Officer | 40,000 0.1728% | $3.00 | $120,000 | +49.60% | ||
2023-12-08 | MICHEL GERARD J | Chief Executive Officer | 34,000 0.1516% | $2.94 | $99,960 | +57.65% | ||
2023-11-17 | Rosalind Advisors, Inc. | director | 100,000 0.6437% | $2.40 | $240,410 | +88.07% | ||
2023-11-17 | Pennell Sandra | SVP of Finance, PFO and PAO | 30,000 0.1952% | $2.43 | $72,900 | +88.07% | ||
2023-11-16 | Vukovic Vojo | Chief Medical Officer | 60,000 0.3928% | $2.48 | $148,800 | +85.02% | ||
2023-11-16 | Hoffman David L. | See Remarks | 40,000 0.2618% | $2.48 | $99,200 | +85.02% | ||
2023-10-13 | Purpura John | Chief Operating Officer | 14,505 0.0944% | $3.44 | $49,897 | +24.85% | ||
2023-08-21 | Sylvester John Richard | director | 10,550 0.093% | $4.80 | $50,640 | -14.17% | ||
2023-03-29 | MICHEL GERARD J | Chief Executive Officer | 19,646 0.0001% | $4.84 | $95,087 | -19.95% | ||
2022-12-14 | Rosalind Advisors, Inc. | director | 15,215 0.1678% | $3.62 | $55,045 | +26.22% | ||
2022-12-14 | SALAMON STEVEN A J | director | 15,215 0.1678% | $3.62 | $55,045 | +26.22% | ||
2022-12-13 | MICHEL GERARD J | Chief Executive Officer | 51,725 0.4573% | $2.90 | $150,003 | +26.22% | ||
2022-07-20 | MICHEL GERARD J | Chief Executive Officer | 62,814 0.6782% | $3.98 | $250,000 | +7.50% | ||
2022-05-16 | Purpura John | Chief Operating Officer | 3,300 0.0396% | $4.61 | $15,213 | -13.01% | ||
2022-05-13 | SALAMON STEVEN A J | 5,000 0.0635% | $5.03 | $25,135 | -15.89% | |||
2022-05-12 | SALAMON STEVEN A J | 6,000 0.0764% | $4.90 | $29,424 | -13.19% | |||
2022-04-19 | Rosalind Advisors, Inc. | 1,600 0.0191% | $6.25 | $10,000 | -36.05% | |||
2022-04-19 | SALAMON STEVEN A J | 1,600 0.0191% | $6.25 | $10,000 | -36.05% |
Rosalind Advisors, Inc. | director | 1038828 4.7121% | $8.10 | 12 | 0 | <0.0001% |
SALAMON STEVEN A J | director | 1121025 2.0653% | $8.10 | 14 | 0 | <0.0001% |
Aharon Gil | 1069710 1.8325% | $8.10 | 3 | 0 | <0.0001% | |
MICHEL GERARD J | Chief Executive Officer | 262345 1.19% | $8.10 | 11 | 0 | <0.0001% |
Vukovic Vojo | Chief Medical Officer | 100000 0.4536% | $8.10 | 2 | 0 | |
Purpura John | Chief Operating Officer | 41526 0.1884% | $8.10 | 7 | 0 | <0.0001% |
Hoffman David L. | See Remarks | 40000 0.1814% | $8.10 | 1 | 0 | |
Pennell Sandra | SVP of Finance, PFO and PAO | 30000 0.1361% | $8.10 | 1 | 0 | |
Sylvester John Richard | director | 10550 0.0479% | $8.10 | 1 | 0 | |
LADD ROBERT | director | 631294 2.8635% | $8.10 | 48 | 11 | |
Taglietti Marco | director | 220000 0.9979% | $8.10 | 2 | 0 | |
Philips Laura A | director | 205299 0.9312% | $8.10 | 8 | 0 | |
HOBBS EAMONN P | President and CEO | 162000 0.7348% | $8.10 | 2 | 0 | |
Taney Richard | Chief Executive Officer | 161000 0.7303% | $8.10 | 5 | 0 | |
HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 160375 0.7275% | $8.10 | 2 | 10 | |
Kandarpa Krishna | Exec. V.P., Chief Medical Off. | 150000 0.6804% | $8.10 | 0 | 1 | |
Koplewicz Harold S | director | 148521 0.6737% | $8.10 | 5 | 0 | |
CORIGLIANO MARK | director | 141225 0.6406% | $8.10 | 0 | 1 | |
WATSON DOUGLAS G | director | 61369 0.2784% | $8.10 | 1 | 0 | |
Miao Graham G | Exec. V.P., CFO | 54000 0.2449% | $8.10 | 1 | 0 | |
LEUNG GABRIEL | director | 15847 0.0719% | $8.10 | 1 | 0 | |
Rueckert William Dodge | director | 7926 0.036% | $8.10 | 3 | 0 | |
Keck Barbra | Chief Financial Officer | 7500 0.034% | $8.10 | 3 | 0 | |
Simpson Jennifer K. | President & CEO | 7500 0.034% | $8.10 | 3 | 0 | |
STOLL ROGER G PHD | director | 5901 0.0268% | $8.10 | 5 | 0 | |
KOLY M S /FA/ | President and CEO | 0 0% | $8.10 | 0 | 2 |
Aigh Capital Management Llc | $11.09M | 8.49 | 2.36M | +99.61% | +$5.54M | 6.59 | |
Vivo Capital | $7.95M | 6 | 1.67M | +94.9% | +$3.87M | 0.7 | |
Bvf Inc Il | $5.73M | 4.33 | 1.2M | +23.14% | +$1.08M | 0.04 | |
The Vanguard Group | $3.26M | 2.46 | 683,686 | +30.97% | +$771,204.01 | <0.0001 | |
CIBC World Markets | $1.24M | 0.94 | 260,280 | -0.44% | -$5,482.78 | <0.01 | |
Geode Capital Management | $1.06M | 0.8 | 223,005 | +31.49% | +$254,777.61 | <0.0001 | |
Hunting Hill Global Capital Llc | $497,978.00 | 0.38 | 104,398 | -36.67% | -$288,336.69 | 0.32 | |
Morgan Stanley | $452,167.00 | 0.34 | 94,794 | +14.22% | +$56,285.95 | <0.0001 | |
BlackRock | $434,423.00 | 0.33 | 91,074 | -0.93% | -$4,092.66 | <0.0001 | |
Marshall Wace | $413,392.00 | 0.31 | 86,665 | -33.55% | -$208,735.17 | <0.01 | |
State Street | $327,971.00 | 0.25 | 68,757 | 0% | +$0 | <0.0001 | |
Northern Trust | $300,977.00 | 0.23 | 63,098 | +4.01% | +$11,595.85 | <0.0001 | |
Levin Capital Strategies | $262,202.00 | 0.2 | 54,969 | +12.18% | +$28,472.12 | 0.03 | |
Citadel Advisors LLC | $204,676.00 | 0.15 | 42,909 | -24.96% | -$68,096.54 | <0.0001 | |
Millennium Management LLC | $175,183.00 | 0.13 | 36,726 | +21.39% | +$30,866.67 | <0.0001 | |
Jane Street Capital | $111,762.00 | 0.08 | 23,430 | New | +$111,762.00 | <0.0001 | |
Wealthplan Investment Management Llc | $83,203.00 | 0.06 | 17,443 | 0% | +$0 | 0.01 | |
Wolverine Trading | $63,932.00 | 0.05 | 13,403 | -31.87% | -$29,907.76 | <0.01 | |
Two Sigma | $61,814.00 | 0.05 | 12,959 | -40.32% | -$41,756.29 | <0.0001 | |
Engineers Gate Manager Lp | $53,863.00 | 0.04 | 11,292 | New | +$53,863.00 | <0.01 | |
Simplex Trading Llc | $52,000.00 | 0.04 | 10,937 | -20.83% | -$13,678.70 | <0.01 | |
Tower Research Capital | $33,314.00 | 0.03 | 6,984 | +132.57% | +$18,989.55 | <0.0001 | |
Royal Bank of Canada | $17,000.00 | 0.01 | 3,500 | +5,203.03% | +$16,679.43 | <0.0001 | |
Wells Fargo | $13,714.00 | 0.01 | 2,875 | +1.91% | +$257.58 | <0.0001 | |
Investors Research Corp | $13,833.00 | 0.01 | 2,900 | -25.64% | -$4,770.00 | <0.01 | |
UBS | $3,807.00 | <0.01 | 798 | +26,500% | +$3,792.69 | <0.0001 | |
Quent Capital | $2,476.00 | <0.01 | 519 | 0% | +$0 | <0.0001 | |
Advisor Group Holdings Inc | $3,201.00 | <0.01 | 671 | -44.13% | -$2,528.36 | <0.0001 | |
Bank of America | $10.00 | <0.01 | 2 | -86.67% | -$65.00 | <0.0001 | |
Lindbrook Capital LLC | $29.00 | <0.01 | 6 | 0% | +$0 | <0.0001 | |
Parallel Advisors, LLC | $5.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
AllSquare Wealth Management, LLC | $5.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
Newbridge Financial Services Group Inc | $5.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
Allworth Financial Lp | $477.00 | <0.01 | 100 | 0% | +$0 | <0.0001 |